The article names three stocks the author considers undervalued: Viking Therapeutics (VKTX), Verizon (VZ), and Royal Caribbean (RCL). Viking closed below $27, after hitting more than $40 less than a month earlier, and its GLP-1 drug VK2735 showed 16% to 19% weight loss over 21 weeks in trials; however, it has no approved drug yet, is burning cash, and has a market cap of about $3 billion. Verizon yields 6.6% with a payout ratio of around 70%, and the author believes fears that SpaceX's Starlink will disrupt telecom are overblown. Royal Caribbean said it will acquire a 50% stake in Sandals and Beaches Resorts for $3 billion; its stock briefly hit a 52-week low of about $222 before recovering, and the company raised guidance to 9% revenue growth and 14% adjusted earnings growth. The author notes Verizon trades at nine times and Royal Caribbean at 11 times estimated future profits.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Get briefings and signals on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the morning, midday and evening briefing of each market and important news as it happens.